Sareum (LON:SAR) Shares Cross Above 50-Day Moving Average – Time to Sell?

Sareum Holdings plc (LON:SAR) shares crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 18.32 ($0.25) and traded as high as GBX 22 ($0.30). Sareum shares last traded at GBX 20.60 ($0.28), with a volume of 275,621 shares trading hands.

Sareum Stock Down 2.1%

The stock’s 50-day moving average price is GBX 18.32 and its 200 day moving average price is GBX 16.75. The firm has a market cap of £25.68 million, a price-to-earnings ratio of -4.87 and a beta of -1.08.

Sareum Company Profile

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.